Insulet Corp. (PODD)
149.29
-0.74
(-0.49%)
USD |
NASDAQ |
Nov 12, 16:00
149.25
-0.04
(-0.03%)
Pre-Market: 08:00
Insulet Price to Book Value : 6.558 for Nov. 12, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 12, 2026 | 6.558 |
| November 11, 2026 | 6.590 |
| November 10, 2026 | 6.504 |
| November 09, 2026 | 6.581 |
| November 06, 2026 | 6.436 |
| November 05, 2026 | 6.858 |
| November 04, 2026 | 7.249 |
| November 03, 2026 | 6.803 |
| November 02, 2026 | 6.748 |
| October 30, 2026 | 6.575 |
| October 29, 2026 | 6.699 |
| October 28, 2026 | 6.542 |
| October 27, 2026 | 6.582 |
| October 26, 2026 | 6.557 |
| October 23, 2026 | 6.546 |
| October 22, 2026 | 6.507 |
| October 21, 2026 | 6.233 |
| October 20, 2026 | 6.266 |
| October 19, 2026 | 6.236 |
| October 16, 2026 | 6.198 |
| October 15, 2026 | 6.096 |
| October 14, 2026 | 5.883 |
| October 13, 2026 | 6.068 |
| October 12, 2026 | 6.142 |
| October 09, 2026 | 5.943 |
| Date | Value |
|---|---|
| October 08, 2026 | 5.907 |
| October 07, 2026 | 5.902 |
| October 06, 2026 | 5.918 |
| October 05, 2026 | 5.958 |
| October 02, 2026 | 5.785 |
| October 01, 2026 | 5.745 |
| September 30, 2026 | 5.731 |
| September 29, 2026 | 6.478 |
| September 28, 2026 | 6.491 |
| September 25, 2026 | 6.638 |
| September 24, 2026 | 6.621 |
| September 23, 2026 | 6.656 |
| September 22, 2026 | 6.797 |
| September 21, 2026 | 6.853 |
| September 18, 2026 | 6.856 |
| September 17, 2026 | 6.902 |
| September 16, 2026 | 6.856 |
| September 15, 2026 | 6.790 |
| September 14, 2026 | 6.720 |
| September 11, 2026 | 6.435 |
| September 10, 2026 | 6.567 |
| September 09, 2026 | 6.725 |
| September 08, 2026 | 6.938 |
| September 04, 2026 | 7.192 |
| September 03, 2026 | 7.343 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Boston Scientific Corp. | 2.500 |
| Abbott Laboratories | 3.640 |
| PROCEPT BioRobotics Corp. | 4.106 |
| The Cooper Cos., Inc. | 1.420 |
| Stryker Corp. | 5.07 |
Price to Book Value Related Metrics
| PE Ratio | 25.59 |
| PS Ratio | 3.274 |
| PEG Ratio | 0.3692 |
| Price to Free Cash Flow | 44.89 |
| Price | 149.29 |
| Earnings Yield | 3.91% |
| Market Cap | 10.36B |
| PEGY Ratio | 0.3692 |
| Operating PE Ratio | 17.78 |
| Normalized PE Ratio | 25.60 |